Paul. J. Hauptman, MD Named Dean of University of Nevada, Reno and Director of Studies for Renown Health | President’s Messages

0

July 14, 2022

Dear Wolf Pack Family,

I am pleased and proud to announce that Paul J. Hauptman, MD, has been named Dean of the University of Nevada, Reno School of Medicine and Academic Director of Renown Health. I would like to thank Melissa Piasecki, MD, for serving as Interim Dean and Academic Director since September 1, 2021.

Dr. Hauptman is a nationally recognized researcher in the field of advanced heart failure outcome evaluation, cardiac care delivery evaluation, and clinical trials. Dr. Hauptman is currently Dean of the Graduate School of Medicine at the University of Tennessee at Knoxville and Director of Studies at the University of Tennessee Medical Center. He begins his appointment on October 17, 2022. Dr. Hauptman’s selection came about following a national search.

Dr. Hauptman has impeccable experience in all areas that we felt were essential to finding our new Dean. He has a passion and a deep understanding of how we should train the next generation of Nevada doctors. He has extensive experience in administering and delivering clinical programs that can have a profound impact on our local communities. He has incredible credentials in the field of research. He has clearly articulated a compelling vision for how he hopes to magnify and expand the education and research efforts of our School of Medicine. Equally important, it was very clear that he believes that as we expand current education and research initiatives to improve the impact of our medical school, he is committed to working collaboratively throughout the community to meet its greatest needs.

As Dean and Director of Studies, Dr. Hauptman will support and advance the academic and clinical integration established under the affiliation between UNR Med and Renown Health.

We want to give Dr. Hauptman and his family a warm welcome to the Wolf Pack Family.

Go pack!

Best regards,

Brian Sandoval
President

Share.

Comments are closed.